首页> 外文期刊>Cellular Physiology and Biochemistry >FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma
【24h】

FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma

机译:FLNA和PGK1是肝细胞癌进展的两个潜在标志物

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aims: Hepatocellular carcinoma (HCC) is one of the most deadly diseases; metastasis and recurrence are the most important factors that affect the therapy of HCC chronically. Until now, the prognosis for the metastasis of HCC had not improved. Recently, several proteins that are related to metastasis and invasion of HCC were identified, but the effective markers still remain to be elucidated. Methods: In this study, comparative proteomics was used to study the differentially expressed proteins in two HCC cell lines MHCC97L and HCCLM9, which have low and high metastatic potentials, respectively. Results: Our findings indicated that filamin A (FLNA) and phosphoglycerate kinase 1 (PGK1) were two significantly differentially expressed proteins, with high expression in HCCLM9 cells, and may influence the metastasis of HCC cells. Conclusion: Taken together with the confirmation of expression on the mRNA level, we propose the use of FLNA and PGK1 as potential markers for the progression of HCC.
机译:背景/目的:肝细胞癌(HCC)是最致命的疾病之一。转移和复发是长期影响肝癌治疗的最重要因素。到目前为止,肝癌转移的预后尚未改善。最近,鉴定了几种与肝癌的转移和侵袭有关的蛋白质,但有效的标记物仍有待阐明。方法:在本研究中,使用比较蛋白质组学研究了两种具有低转移潜能和高转移潜能的HCC细胞系MHCC97L和HCCLM9的差异表达蛋白。结果:我们的发现表明,纤维蛋白A(FLNA)和磷酸甘油酸激酶1(PGK1)是两种差异表达明显的蛋白,在HCCLM9细胞中高表达,并可能影响HCC细胞的转移。结论:结合在mRNA水平上的表达确认,我们建议使用FLNA和PGK1作为HCC进展的潜在标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号